Under construction – not a live service
Sign in
Not yet recruitingNo phase

DOTATATE PET for Meningioma Radiation Planning

Key facts

Who runs it
British Columbia Cancer Agency
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
36 people, planned
Started
Jun 2025
Expected to end
31 Dec 2027
Type of study
Interventional
Treatments tested
  • DOTATATE-PET scan
Record updated
22 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age ≥ 18 years old
  • Able and willing to comply with the study procedures
  • Intact meningioma requiring definitive radiation
  • Post-operative meningioma requiring adjuvant radiation
  • No prior radiation therapy or medical therapy directed at the tumour

Who cannot take part

  • Breastfeeding or pregnancy
  • Claustrophobia or inability to lie still in a supine position
  • Unwillingness or inability to provide informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

68Ga-DOTATATE-based radionuclides are a novel modality in the diagnosis and treatment of central nervous system meningioma. DOTATATE is a ligand for the SSTR (somatostatin receptor), which is expressed in meningioma but not in normal brain or bone. It is also more effective than MRI in delineating tumor, which is the current imaging standard for assessing meningioma. For radiation planning, it can help to reduce the risk of geometrical miss, identify area that require dose-escalation, and reduce dose to normal tissue. The purpose of the study is to compare the radiation therapy (RT) contouring and planning for meningioma with and without the use of 68Ga-DOTATATE-PET

The group in the trial

  • DOTATATE-PET scanTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Exploratory Analysis of DOTATATE PET for Meningioma Radiation Planning
Record updated
22 April 2025